|  View All

News from NINDS

artist's rendering of glioma attacked by immune system

Combination treatment for common glioma type shows promise in mice

Tuesday, February 16, 2021

In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas—a type of slow-growing glioma—and found tumor regression in 60 percent of the mice treated.

Read Full Article

Doctor Walter Koroshetz